US Broker Ratings

Becton, Dickinson and Company (BDX) Stock Analysis: A 17.97% Potential Upside Beckons Investors

Becton, Dickinson and Company (NYSE: BDX), a venerable player in the healthcare sector, is garnering attention from investors thanks to its robust market presence and a potential upside of 17.97%...

Tempus AI, Inc. (TEM) Investor Outlook: Exploring a 48% Potential Upside in Healthcare Tech

Tempus AI, Inc. (NASDAQ: TEM) has emerged as a significant player in the healthcare technology sector, operating at the intersection of artificial intelligence and healthcare services. The company’s innovative approach,..

Charles River Laboratories Inte (CRL) Stock Analysis: Navigating Potential 13% Upside with Strong Buy Ratings

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $8.59 billion,..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 12.73% Upside Potential in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a key player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of $11.14 billion,..

Labcorp Holdings Inc. (LH) Stock Analysis: A Diagnostic Leader with a 14% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, particularly in diagnostics and research, stands out with a market capitalization of $22.36 billion. Headquartered in Burlington, North..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 30% Upside Potential

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, is gaining attention from investors due to its strong growth metrics and potential upside. As a company..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 41% Potential Upside

argenx SE (NASDAQ: ARGX) stands as a formidable entity within the biotechnology sector, capturing the interest of investors with its innovative approach to treating autoimmune diseases. Founded in 2008 and..

The Ensign Group, Inc. (ENSG) Stock Analysis: Strong Revenue Growth and a 6.36% Upside Potential

For investors seeking opportunities in the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) offers a compelling prospect. With a market capitalization of $12.04 billion, Ensign operates primarily in the..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with 30.90% Potential Upside

Revvity, Inc. (NASDAQ: RVTY), formerly known as PerkinElmer, Inc., has been making significant strides in the healthcare sector since its inception in 1937. With its recent rebranding and strategic focus..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: An In-Depth Look at Investor Ratings and Valuation Insights

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, captures investor attention with its strategic position in the drug manufacturing industry, particularly in specialty and generic..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 29.9% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Solventum Corporation (SOLV) an intriguing prospect. With a market capitalization of $12.04 billion, Solventum operates in the Medical Instruments & Supplies..

Doximity, Inc. (DOCS) Investor Outlook: Assessing a 57.67% Potential Upside in Healthcare’s Digital Revolution

Doximity, Inc. (NYSE: DOCS) stands as a leading digital platform tailor-made for healthcare professionals in the United States, providing a comprehensive suite of digital tools that enhance medical collaboration and..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 23.70% Potential Upside Amidst Healthcare Evolution

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, continues to captivate investor interest with its robust market presence and strategic evolution in health solutions. Headquartered in..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a Potential 32.89% Upside in the Healthcare Sector

Avantor, Inc. (AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $5.57 billion, Avantor is headquartered in Radnor,..

Humana Inc. (HUM) Investor Outlook: Navigating Healthcare Potential with a 24.97% Upside

Humana Inc. (HUM), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors looking to navigate the dynamic landscape of healthcare services in the United States...

Vertex Pharmaceuticals (VRTX) Stock Analysis: Uncovering a 17% Potential Upside in the Booming Biotech Sector

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is a prominent player in the biotechnology sector, with a market capitalization of $116.01 billion. Renowned for its groundbreaking treatments, Vertex focuses on specialty markets,..

Insmed Incorporated (INSM) Investor Outlook: Robust Growth Potential Despite Current Headwinds

Insmed Incorporated (NASDAQ: INSM), a biotechnology company based in Bridgewater, New Jersey, presents a compelling opportunity for investors focused on the healthcare sector. With a market capitalization of $30.21 billion,..

BioNTech SE (BNTX) Stock Analysis: Exploring a 34.82% Upside Potential in the Biotech Sector

BioNTech SE (NASDAQ: BNTX), a pioneering force in the biotechnology sector, continues to capture investor attention with its robust pipeline of immunotherapies targeting cancer and infectious diseases. Headquartered in Mainz,..

Insulet Corporation (PODD) Stock Analysis: Unveiling a 49.53% Potential Upside Amid Strong Buy Ratings

Investors seeking opportunities in the healthcare sector may find Insulet Corporation (PODD) an intriguing prospect. A leader in the development and sale of insulin delivery systems, Insulet has made significant..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 22.22% Potential Upside in the Healthcare Sector

As the healthcare sector continues to evolve, AptarGroup, Inc. (NYSE: ATR) presents an intriguing opportunity for investors. With a market capitalization of $8.67 billion, AptarGroup is positioned as a leader..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds